T. Rowe Price Investment Management, Inc. Generation Bio Co. Transaction History

T. Rowe Price Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.5 - $5.67 $456,750 - $739,935	130,500 Added 3.86%	3,511,456 $19.3 Million
Q1 2023 May 15, 2023	SELL	$3.61 - $7.01 $710,444 - $1.38 Million	-196,799 Reduced 5.5%	3,380,956 $14.5 Million
Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $348,205 - $644,084	95,138 Added 2.73%	3,577,755 $14.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.68 - $8.34 $16.3 Million - $29 Million	3,482,617 New	3,482,617 $18.5 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $79.7M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.